In vivo binding of [11C]SKF 75670 and [11C]SKF 82957 in rat brain: Two dopandne D-1 receptor agonist ligands

Life Sciences

Volumn 58, Issue 19, 1996, Pages 1661-1670

  DaSilva, Jean N ^a,b   Wilson, Alan A ^a   Valente, Celia M ^a,b   Hussey, Doug ^a   Wilson, David ^a   Houle, Sylvain ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

D1 receptors; Hit affinity agonist state; Positron emission tomography; Striatum 11C SKF 75670; 11C SKF 82957

Indexed keywords

BENZAZEPINE DERIVATIVE; CARBON; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; SK&F 75670; SKF 82957; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CARBON 11; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; RADIOLIGAND; RITANSERIN; SEROTONIN 2 ANTAGONIST; SULPIRIDE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; BRAIN; MALE; METABOLISM; RADIOASSAY; RAT; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; BINDING COMPETITION; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DISTRIBUTION; DRUG SELECTIVITY; DRUG SPECIFICITY; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; LIPOPHILICITY; NONHUMAN; OLFACTORY NUCLEUS; POSITRON EMISSION TOMOGRAPHY; RECEPTOR AFFINITY;

ANIMALS; AUTORADIOGRAPHY; BENZAZEPINES; BRAIN; CARBON RADIOISOTOPES; DOPAMINE AGONISTS; MALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; TISSUE DISTRIBUTION;

EID: 0029664429     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00141-5     Document Type: Article

References (46)

1. H.B. NIZNIK, N.Y. OTSUKA, A. DUMBRILLE-ROSS, D. GRIGORIADIS, A. TIRPAK and P. SEEMAN, J. Biol. Chem. 261 8397-8406 (1986).
2. E.J. HESS, G. BATTAGLIA, A.B. NORMAN, L.C. IORIO and I. CREESE, Eur. J. Pharmacol. 121 31-38 (1986).
3. K. KIMURA, S. SELA, C. BOUVIER, D.K. GRANDY and A. SIDHU, J. Neurochem. 64 2118-2124 (1995).
4. J.W. KEBABIAN and D.B. CALNE, Nature 277 90-96 (1979).
5. J.C. STOOF and J.W. KEBABIAN, Life Sci. 35 2281-2296 (1984).
6. P. SEEMAN and D. GRIGORIADIS, Neurochem. Int. 10 1-25 (1987).
7. H.B. NIZNIK and H.H.M. VAN TOL, J. Psychiatr. Neurosci. 17 158-180 (1992).
8. L.C. MAHAN, R.M. BURCH, F.J. MONSMA JR. and D.R. SIBLEY, Proc. Natl. Acad. Sci. USA. 87 2196-2200 (1990).
9. A.S. UNDIE and E. FRIEDMAN, J. Pharmacol. Exp. Ther. 253 987-992 (1990).
10. D. CLARK and F.J. WHITE, Synapse 1 347-388 (1987).
11. J.L. WADDINGTON and K.M. O'BOYLE, Pharmac. Ther. 43 1-52 (1989).
12. E.J. HESS, H.S. BRACHA, J.E. KLEINMAN and I. CREESE, Life Sci. 40 1487-1497 (1987).
13. P. SEEMAN, N.H. BZOWEJ, H.C. GUAN, C. BERGERON, G.P. REYNOLDS, E.D. BIRD, P. RIEDERER, K. JELLINGER and W.W. TOURTELLOTTE, Neuropsychopharmacol. 1 5-15 (1987).
14. M. GUTTMAN, Neurologic Clinics 10 377-386 (1992).
15. A. CROSS and M. ROSSOR, Eur. J. Pharmacol. 88 223-229 (1983).
16. J.N. JOYCE, N. LEXOW, E. BIRD and A. WINOKUR, Synapse 2 546-557 (1988).
17. F. FILLOUX, M.V. WAGSTER, S. FOLSTEIN, D.L. PRICE, J.C. HEDREEN, T.M. DAWSON and J.K. WAMSLEY, Exp. Neurol. 110 219-227 (1990).
18. B. MAZIÈRE, H.H. COENEN, C. HALLDIN, K. NÅGREN and V.W. PIKE, Nucl. Med. Biol. 19 497-512 (1992).
19. A.L. BROWNELL, P. HANTRAYE, U. WULLNER, L. HAMBERG, T. SHOUP, D.R. ELMALEH, D.M. FRIM, B.K. MADRAS, G.L. BROWNELL, B.R. ROSEN and O. ISACSON, Exp. Neurol. 125 41-51 (1994).
20. G. SEDVALL, P. KARLSSON, A. LUNDIN, M. ANVRET, T. SUHARA, C. HALLDIN and L. FARDE, Eur. Arch. Psychiatry Clin. Neurosci. 243 249-255 (1994).
21. C.G. SEDVALL, L. FARDE, H. HALL, C. HALLDIN, P. KARLSSON, S. BRENE, N. LINDEFORS, H. PERSSON, R.E. CHIPKIN, M. EHRLICH and P. GREENGARD, Clin. Neuropharmacol. 15 466A-467A (1992).
22. P. KARLSSON, L. FARDE, C. HALLDIN and A.-L. NORDSTRÖM, J. Cereb. Blood Flow Metab. 13 S556 (1993).
23. J.O. RINNE, A. LAIHINEN, K. NAGREN, J. BERGMAN, O. SOLIN, M. HAAPARANTA, U. RUOTSALAINEN and U.K. RINNE, J. Neurosci. Res. 27 494-499 (1990).
24. H. SHINOTOH, O. INOUE, K. HIRAYAMA, A. AOTSUKA, M. ASAHINA, T. SUHARA, T. YAMAZAKI and Y. TATENO, J. Neurol. Neurosurg. Psychiatry 56 467-472 (1993).
25. A.O. LAIHINEN, J.O. RINNE, H.M. RUOTTINEN, K.Å. NÅGREN, P. K. LEHIKOINEN, V.J. OIKONEN, U.H. RUOTSALAINEN, AND U.K. RINNE, J. Nucl. Med. 35 1916-1920 (1994).
26. P. SEEMAN and J.M. SCHAUS, Eur. J. Pharmacol. 203 105-109 (1991).
27. A. SIDHU, Biochemistry 22 8768-8776 (1988).
28. P.H. ROSEBOOM and M.E. GNEGY, Mol. Pharmacol. 34 148-156 (1989).
29. S.R. GEORGE, M. WATANABE, T. DI PAOLO, P. FALARDEAU, F. LABRIE and P. SEEMAN, Endocrinology 117 690-697 (1985).
30. E.K. RICHFIELD, J.B. PENNEY and A.B. YOUNG, Neuroscience 30 767-777 (1989).
31. M. MAMELAK, S. CHIU and R.K. MISHRA, Eur. J. Pharmacol. 233 175-176 (1993).
32. J.N. DASILVA, A.A. WILSON, J.N. NOBREGA, D. JIWA and S. HOULE, Appl. Radiat. Isot. (In Press, 1996).
33. J.L. NEUMEYER, N. BAINDUR., H.B. NIZNIK, H.C. GUAN and P. SEEMAN, J. Med. Chem. 34 3366-3371 (1991).
34. P.H. ANDERSEN and J.A. JANSEN, Eur. J. Pharmacol. 188 335-347 (1990).
35. J. WEINSTOCK, J.P. HIEBLE and J.W. WILSON III, Drugs of the Future 10 645-697 (1985).
36. A.A. WILSON, J.N. DASILVA and S. HOULE, Nucl. Med. Biol. 23 (In Press, 1996).
37. J.E. LEYSEN, W. GOMMEREN, P. VAN GOMPEL, J. WYNANTS, P.F.M. JANSSEN, and P.M. LADURON, Molecular Pharmacol. 27 600-611 (1985).
38. I. PETTERSSON, K. GUNDERTOFTE, J. PALM and T. LILJEFORS, J. Med. Chem. 35 502-507 (1992).
39. N. BAINDUR, M. TRAN, H.B. NIZNIK, H.C. GUAN, P. SEEMAN and J.L. NEUMEYER, J. Med. Chem. 35 67-72 (1992).
40. S. ROSENZWEIG-LIPSON and J. BERGMAN, J. Pharmacol. Exp. Ther. 267 765-775 (1993).
41. K.K. GNANALINGHAM, D.D. EROL, A.J. HUNTER, L.A. SMITH, P. JENNER and C.D. MARSDEN, Psychopharmacology 117 275-286 (1995).
42. A. DUBOIS, M. SAVASTA, O. CURET and B. SCATTON, Neuroscience 19 125-137 (1986).
43. M. SAVASTA, A. DUBOIS and B. SCATTON, Brain Res. 375 291-301 (1986).
44. C. HALLDIN, C. FOGED, L. FARDE, P. KARLSSON, K. HANSEN, F. GRONVALD, G.G. SWAHN, H. HALL and G. SEDVALL, Nucl. Med. Biol. 20 945-953 (1993).
45. K.M. O'BOYLLE and J.L. WADDINGTON, Neuropharmacology 31 177-183, 1992.
46. F.J. MONSMA JR., L.C. MAHAN, L.D. MCVITTIE, C.R. GERFEN and D.R. SIBLEY, Proc. Natl. Acad. Sci. USA. 87 6723-6727 (1990).